ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Super-Resolution Ultrasound Based Cell Tracking With Polymeric Nanobubbles.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Tracking the fate of transplanted cells in vivo remains a major challenge for the development and monitoring of cell-based therapies. Here, we report a nanobubble (NB) based acoustic labeling strategy that enables ultrasound localization microscopy (ULM) to track transplanted cells in tumors with single-cell-scale sensitivity and super-resolution spatial precision. We developed stable, biocompatible poly(butyl cyanoacrylate) NB that are efficiently internalized by cells and generate strong intracellular ultrasound signals. Furthermore, ULM allows the real-time visualization of individual cells, their localization, and trajectory reconstruction in flow phantoms and murine breast cancers. In the latter, NB-labeled bone marrow-derived mononuclear cells were tracked in vivo following intra-arterial injection, whereas unlabeled cells remained undetectable. By integrating cell trajectories with microbubble-based super-resolution vascular maps, our approach allows identification of the blood vessels that delivered the cells. This clinically compatible imaging strategy expands the application of ULM beyond vascular mapping and provides a platform for high-resolution, dynamic monitoring of cell-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.